Boston Scientific pairs with Accenture to launch Advantics HF patient care app

Boston Scientific (NYSE:BSX) said today it partnered with Accenture to develop Advantics care pathway transformation, a cloud-based digital health platform for hospitals designed to improve outcomes and reduce cost for treating patients with chronic cardiovascular diseases.

The companies said Advantics is designed to aid healthcare providers in making more informed decisions based on patient population health patterns and data analytics.

“Boston Scientific and Accenture designed this digital health platform to help providers standardize care, reduce overall length of stay and lower readmission rates. The care pathway transformation solution is designed to support healthcare professionals and patients to have more informed relationships, leading to better health outcomes and lower costs for health systems. Together, we are addressing an acute need for some of the most costly chronic conditions,” Boston Scientific CEO Mike Mahoney said in a press release.

The platform will operate around pathway analytics, or how patients move through hospital systems, care management, monitoring how patients are diagnosed, treated and monitored, and patient engagement tracking, examining how patients are educated, monitored and communicated with during and after hospitalization, Boston Scientific said.

“Socio-economic changes are driving the market to move to value-based care, and new data-driven care transformation services are a great enabler of delivering high-quality healthcare at the right cost. Working together with Boston Scientific, we are able to bring to market digital capabilities and analytics-driven insights that focus on improving patient and economic outcomes,” Accenture senior managing director Anne O’Riordan said in prepared remarks.

Currently, the platform has been designed around patients with heart failure, but the companies said they plan to expand it to additional disease states.

During development, the companies worked with Sweden’s Karilinska University Hospital and Finland’s Tampere Heart Hospital to assess “current state of care delivery” for heart failure patients.

“The collaboration with Boston Scientific and Accenture exposed significant opportunities to increase provider collaboration and improve the quality of care that patients experience when coming to our hospital. For example, we identified a 25% unnecessary heart failure readmissions rate, and therefore a definite need for better care coordination, supported by modern technology and processes that can decrease overall costs,” Tampere Heart Hospital CEO Dr. Kari Niemelä said in a prepared statement.

The companies plan to offer the solution to hospitals in the U.K. and Scandanavia, with pilot projects planned for Europe and the U.S.

The post Boston Scientific pairs with Accenture to launch Advantics HF patient care app appeared first on MassDevice.

from MassDevice http://ift.tt/1ORLmnJ